ZA200006123B - Feline CD80, feline CD86, feline CD28, and feline CTLA-4 nucleic acid and polypeptides. - Google Patents

Feline CD80, feline CD86, feline CD28, and feline CTLA-4 nucleic acid and polypeptides.

Info

Publication number
ZA200006123B
ZA200006123B ZA200006123A ZA200006123A ZA200006123B ZA 200006123 B ZA200006123 B ZA 200006123B ZA 200006123 A ZA200006123 A ZA 200006123A ZA 200006123 A ZA200006123 A ZA 200006123A ZA 200006123 B ZA200006123 B ZA 200006123B
Authority
ZA
South Africa
Prior art keywords
feline
ctla
provides
nucleic acid
present
Prior art date
Application number
ZA200006123A
Other languages
English (en)
Inventor
Ellen Collison
Stephen M Hash
In-Soo Choi
Original Assignee
Texas A & M Univ Sys
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas A & M Univ Sys filed Critical Texas A & M Univ Sys
Publication of ZA200006123B publication Critical patent/ZA200006123B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70521—CD28, CD152
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70532—B7 molecules, e.g. CD80, CD86
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA200006123A 1998-05-01 2000-10-30 Feline CD80, feline CD86, feline CD28, and feline CTLA-4 nucleic acid and polypeptides. ZA200006123B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7169998A 1998-05-01 1998-05-01

Publications (1)

Publication Number Publication Date
ZA200006123B true ZA200006123B (en) 2002-01-20

Family

ID=22102998

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200006123A ZA200006123B (en) 1998-05-01 2000-10-30 Feline CD80, feline CD86, feline CD28, and feline CTLA-4 nucleic acid and polypeptides.

Country Status (20)

Country Link
EP (1) EP1073741B1 (pl)
JP (3) JP2002513571A (pl)
KR (2) KR100869861B1 (pl)
AT (1) ATE481485T1 (pl)
AU (1) AU4070399A (pl)
BR (1) BR9910153A (pl)
CA (1) CA2327539A1 (pl)
CZ (1) CZ20003935A3 (pl)
DE (1) DE69942765D1 (pl)
ES (1) ES2352745T3 (pl)
HU (1) HUP0102806A3 (pl)
IL (4) IL139371A0 (pl)
NO (1) NO20005481L (pl)
NZ (1) NZ507794A (pl)
PL (1) PL199352B1 (pl)
RU (2) RU2263145C2 (pl)
SK (1) SK16172000A3 (pl)
UA (2) UA77382C2 (pl)
WO (1) WO1999057271A2 (pl)
ZA (1) ZA200006123B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094874B2 (en) 2000-05-26 2006-08-22 Bristol-Myers Squibb Co. Soluble CTLA4 mutant molecules
US7183376B2 (en) 2000-06-23 2007-02-27 Maxygen, Inc. Variant B7 co-stimulatory molecules
CA2411828A1 (en) 2000-06-23 2002-01-03 Maxygen, Inc. Novel co-stimulatory molecules
RU2317329C2 (ru) * 2005-05-04 2008-02-20 Дмитрий Валериевич Федосов Пара синтетических олигонуклеотидов-праймеров, используемых для выявления днк провируса лейкоза кошек эндогенного и экзогенного типа, и условия полимеразной цепной реакции с их использованием
ES2642184T3 (es) * 2012-01-05 2017-11-15 Deutsches Krebsforschungszentrum Péptidos para su uso en el tratamiento y diagnóstico de cánceres positivos a IDH1 R132H
CN110184283A (zh) * 2019-04-30 2019-08-30 吉林农业大学 一种检测虎细小病毒的lamp-lfd试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658669B1 (fr) * 1990-02-20 1992-07-24 Souriau & Cie Connecteur a verrouillage par levier.
DE69226871T3 (de) * 1991-06-27 2009-09-24 Bristol-Myers Squibb Co. CTL4A-Rezeptor, ihn enthaltenden Fusionsproteine und deren Verwendung
AU7638894A (en) * 1993-09-03 1995-03-22 Miyuki Azuma B70(b7-2):ctla-4 bonding protein
JP3907698B2 (ja) * 1994-10-03 2007-04-18 アメリカ合衆国 抗原を発現する組み換えウイルスと免疫刺激分子を発現する組み換えウイルスとを含む組成物
JP4025400B2 (ja) * 1997-04-16 2007-12-19 財団法人化学及血清療法研究所 新規免疫制御分子及びその製造方法

Also Published As

Publication number Publication date
RU2377302C2 (ru) 2009-12-27
ES2352745T3 (es) 2011-02-22
KR100869861B1 (ko) 2008-11-24
IL184201A (en) 2010-11-30
IL139371A (en) 2009-08-03
BR9910153A (pt) 2001-10-02
KR20010082542A (ko) 2001-08-30
EP1073741A2 (en) 2001-02-07
EP1073741B1 (en) 2010-09-15
PL345975A1 (en) 2002-01-14
NO20005481L (no) 2000-12-29
WO1999057271A3 (en) 2000-03-02
CA2327539A1 (en) 1999-11-11
RU2005108676A (ru) 2006-09-10
HUP0102806A3 (en) 2005-12-28
UA77382C2 (en) 2006-12-15
DE69942765D1 (de) 2010-10-28
IL139371A0 (en) 2001-11-25
SK16172000A3 (sk) 2002-10-08
JP2010104369A (ja) 2010-05-13
UA87470C2 (ru) 2009-07-27
PL199352B1 (pl) 2008-09-30
HK1034537A1 (en) 2001-10-26
ATE481485T1 (de) 2010-10-15
JP2010252804A (ja) 2010-11-11
HUP0102806A2 (hu) 2001-11-28
KR20040053251A (ko) 2004-06-23
AU4070399A (en) 1999-11-23
CZ20003935A3 (cs) 2001-12-12
JP2002513571A (ja) 2002-05-14
NZ507794A (en) 2003-10-31
NO20005481D0 (no) 2000-10-31
WO1999057271A2 (en) 1999-11-11
IL184202A (en) 2010-11-30
RU2263145C2 (ru) 2005-10-27
WO1999057271A9 (en) 2000-04-27

Similar Documents

Publication Publication Date Title
AU4078599A (en) Expression vectors for stimulating an immune response and methods of using the same
BR0010361A (pt) Seq ências genÈmicas de neisseria e uso destas
AU2003278729A8 (en) Regulated bacterial lysis for gene vaccine vector delivery and antigen release
SG152917A1 (en) Neisseria meningitidis antigens
WO1999024578A3 (en) Neisserial antigens
NZ532665A (en) Neisseria meningitidis antigens and compositions
WO2005025614A3 (en) Improvements in vaccination
AU8127494A (en) Chimeric proteins comprising borrelia polypeptides: uses therefor
ZA200006123B (en) Feline CD80, feline CD86, feline CD28, and feline CTLA-4 nucleic acid and polypeptides.
EP0989858A4 (en) PEPTIDOMIMETICS INHIBITORS OF CD28 / CTLA-4, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHOD OF USE THEREOF
HU9801384D0 (en) Clostridium perfringeus vaccine
EP2172214A3 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
MXPA04003969A (es) Sistema de expresion de acido nucleico regulado.
DE69922212D1 (de) Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp)
NO20005482L (no) Rekombinant virus og anvendelser derav samt vaksine som omfatter nevnte virus.
IL149415A0 (en) Adjuvanted genetic vaccines
WO2001032204A3 (en) Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression
SI1227840T1 (sl) Genetske vakcine z adjuvansom
NZ334649A (en) Iron regulated promoter derived from an aerobactin gene promoter